Before asking participants about their expectations for the drugs impacts on the food system, all participants were given a brief background on the topic, which said: GLP-1 drugs decrease users appetite, which results in fewer calories consumed
The clinical workflow remains consistent with standard GLP-1/GIP therapy: baseline labs, initial dosing at 2.5 mg weekly, titration every 4 weeks to tolerance, and ongoing provider monitoring
GHK-Cu rebuilds collagen and connective tissue
It becomes immediately obvious that these are not the same tool
When you take this medication, it mimics these hormones to signal your brain that you are satisfied, which effectively reduces your appetite
If you find yourself in a cycle of anxiety about your weight, poor sleep from the anxiety, cortisol elevation from the poor sleep, and weight gain from the cortisol, seek professional support